MARKET

NONOF

NONOF

Novo-Nordisk A S
OTCPK
46.05
+2.69
+6.20%
Closed 09:48 08/14 EDT
OPEN
46.24
PREV CLOSE
43.36
HIGH
46.24
LOW
46.05
VOLUME
600
TURNOVER
27.73K
52 WEEK HIGH
46.77
52 WEEK LOW
25.45
MARKET CAP
154.30B
P/E (TTM)
11.51
1D
5D
1M
3M
1Y
5Y
1D
I Underestimated Eli Lilly: Retatrutide Changes The Risk/Reward (Rating Upgrade)
Seeking Alpha · 3d ago
The Market Is (Still) Underestimating Novo Nordisk
Seeking Alpha · 3d ago
Weekly Report: what happened at NONOF last week (0803-0807)?
Weekly Report · 5d ago
Eli Lilly: 'Strong Buy' On Retatrutide Obesity Drug And EBGLYSS Maintenance Label Expansion
Seeking Alpha · 08/07 22:29
Lilly, Novo antitrust case over GLP-1s dismissed in Texas
Seeking Alpha · 08/07 15:08
Novo Nordisk: Dismal Q2 Earnings, Operational Frailties Warrant Rating Downgrade
Seeking Alpha · 08/07 14:55
Stock Index Futures Gain With All Eyes on Key U.S. Jobs Report
Barchart · 08/07 05:26
Novo Nordisk: The Market Has Lost Its Mind, Too Cheap To Ignore
Seeking Alpha · 08/06 16:33
More
About NONOF
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S stock information, including OTCPK: NONOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NONOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NONOF stock methods without spending real money on the virtual paper trading platform.